Drug major GlaxoSmithKline (GSK) has unethically tested a breast cancer drug on poor patients in India for approval for new drugs in the Europe Union, said a study. According to an investigation by Mumbai-based Centre for Studies in Ethics and Rights, the firm tested lapatinib on patients flouting Indian Council of Medical Research's (ICMR) ethical guidelines.This trial required seriously ill patients who had not received treatment for their condition.
"Foreign companies are treating India as a heaven for clinical trials, but it is proving hell for India." So said an Indian Supreme Court judge on 30 September as he pressed the pause button on the country's clinical trials, ruling ... Read Post
Two people working as brokers for a Hyderabad-based pharmaceutical company were Friday arrested in Andhra Pradesh's Guntur district for engaging poor women for unauthorised drug trials, police said. Kommu Karunamma and Shaikh Jameel... Read Post